Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients

Inflammation Research

Volumn 50, Issue SUPPL. 1, 2001, Pages

  Combe, B ^a   Velicitat P ^b   Garzon N ^c   Bluhmki, E ^d  

^a LAPEYRONIE HOSPITAL   (France)

^b BOEHRINGER INGELHEIM   (France)

^c Hospital Los Montalvos   (Spain)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Intramuscular; Meloxicam; Non steroidal anti inflammatory drugs; Rheumatoid arthritis; Tolerability

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; MUSCULOSKELETAL DISEASE; PAIN; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TABLET;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; THIAZINES; THIAZOLES;

EID: 0035083778     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Clinical features of rheumatoid arthritis
2. New therapies for rheumatoid arthritis
3. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs
4. Intramuscular use of NSAIDs
5. Introduction: Mechanism of action of NSAIDs
6. Selective inhibition of human cyclo-oxygenase-2 by meloxicam
7. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers
8. Review of clinical trials and benefit/risk ratio of meloxicam
9. Pharmacological, pharmacokinetic and clinical profile of meloxicam
10. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the Safety and Efficacy Large Scale Evaluation of COX inhibiting Therapies (SELECT) trial in osteoarthritis
11. The gastroenterologist's caseload: Contribution of the rheumatologist
12. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients
13. Efficacy and tolerance of meloxicam, a new NSAID, in daily oral doses of 15, 30 and 60 mg in comparison to 20 mg piroxicam in patients with rheumatoid arthritis
14. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis
15. Efficacy and safety of meloxicam in patients with rheumatoid arthritis
16. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis
17. Pharmacokinetics and tolerability of meloxicam after i.m. administration
18. Effect of food on the pharmacokinetics of meloxicam after oral administration
19. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica
20. Local and systemic tolerability of piroxicam after intramuscular administration in healthy volunteers
21. Local tissue tolerability of meloxicam, a new NSAID: Indications for parenteral, dermal and mucosal administration
22. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
23. Self report questionnaire scores in rheumatoid arthritis compared with traditional, physical radiographic and laboratory measures
24. Efficacité comparée du kétoprofène en fonction de sa voie d'administration (intramusculaire ou per os). Une étude en double aveugle contre placebo au cours de la polyarthrite rhumatoïde
25. Tolerability of multiple administration of intramuscular meloxicam: A comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis
26. Meloxicam: A selective COX-2 inhibitor nonsteroidal anti-inflammatory drug
27. Safety of meloxicam: A global analysis of clinical trials
28. Elevated serum CPK after drug injections
29. A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs
30. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration